CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer

por Catalán, Rodrigo, Orozco-Morales, Mario, Hernández-Pedro, Norma Y., Guijosa, Alberto, Colín-González, Ana L., Ávila-Moreno, Federico, Arrieta, Oscar
Publicado 2020

Locoregional control and toxicity after pleurectomy/decortication and intensity‐modulated pleural radiation therapy in patients with malignant pleural mesothelioma

por Arrieta, Oscar, Lozano‐Ruiz, Francisco, Blake‐Cerda, Monika, Catalán, Rodrigo, Lara‐Mejía, Luis, Salinas, Miguel Ángel, Maldonado‐Magos, Federico, Corona‐Cruz, José F.
Publicado 2020

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

por Arrieta, Oscar, Catalán, Rodrigo, Guzmán-Vazquez, Silvia, Barrón, Feliciano, Lara-Mejía, Luis, Soto-Molina, Herman, Ramos-Ramírez, Maritza, Flores-Estrada, Diana, de la Garza, Jaime
Publicado 2020

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

por Barrón, Feliciano, Sánchez, Roberto, Arroyo-Hernández, Marisol, Blanco, Carolina, Zatarain-Barrón, Zyanya L., Catalán, Rodrigo, Ramos-Ramírez, Maritza, Cardona, Andrés F., Flores-Estrada, Diana, Arrieta, Oscar
Publicado 2020

Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors

por Orozco-Morales, Mario, Avilés-Salas, Alejandro, Hernández-Pedro, Norma, Catalán, Rodrigo, Cruz-Rico, Graciela, Colín-González, Ana Laura, Dosal-Mancilla, Elsa, Barrios-Bernal, Pedro, Arrieta, Oscar
Publicado 2021

T-cell tolerant fraction as a predictor of immune-related adverse events

por Ostmeyer, Jared, Park, Jason Y, von Itzstein, Mitchell S, Hsiehchen, David, Fattah, Farjana, Gwin, Mary, Catalan, Rodrigo, Khan, Shaheen, Raj, Prithvi, Wakeland, Edward K, Xie, Yang, Gerber, David E
Publicado 2023

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

por Avilés-Salas, Alejandro, Díaz-García, Diego A., Lara-Mejía, Luis, Cardona, Andrés F., Orozco-Morales, Mario, Catalán, Rodrigo, Hernández-Pedro, Norma Y., Rios-Garcia, Eduardo, Ramos-Ramírez, Maritza, Arrieta, Oscar
Publicado 2022

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells

por Cruz-Rico, Graciela, Avilés-Salas, Alejandro, Popa-Navarro, Xitlally, Lara-Mejía, Luis, Catalán, Rodrigo, Sánchez-Reyes, Roberto, López-Sánchez, Dennis, Cabrera-Miranda, Luis, Aquiles Maldonado-Martínez, Héctor, Samtani-Bassarmal, Suraj, Arrieta, Oscar
Publicado 2021

Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis

por Guijosa, Alberto, Freyria, Ana, Espinosa‐Fernandez, Jose Rodrigo, Estrada‐Mena, Francisco J., Armenta‐Quiroga, Ana Sofía, Ortega‐Treviño, Maria Fernanda, Catalán, Rodrigo, Antonio‐Aguirre, Bani, Villarreal‐Garza, Cynthia, Perez‐Ortiz, Andric C.
Publicado 2022

Modifying factors of PD‐L1 expression on tumor cells in advanced non‐small‐cell lung cancer

por Avilés‐Salas, Alejandro, Flores‐Estrada, Diana, Lara‐Mejía, Luis, Catalán, Rodrigo, Cruz‐Rico, Graciela, Orozco‐Morales, Mario, Heredia, David, Bolaño‐Guerra, Laura, Soberanis‐Piña, Pamela Denisse, Varela‐Santoyo, Edgar, Cardona, Andrés F., Arrieta, Oscar
Publicado 2022

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

por Muñoz-Montaño, Wendy, Muñiz-Hernández, Sae, Avilés-Salas, Alejandro, Catalán, Rodrigo, Lara-Mejía, Luis, Samtani-Bassarmal, Suraj, Cardona, Andres F., Mendoza-Desión, Jorge, Hernández-Cueto, Daniel, Maldonado, Altagracia, Baay-Guzmán, Guillermina, Huerta-Yepes, Sara, Arrieta, Oscar
Publicado 2021

Persistent high levels of carcinoembryonic antigen after tumor resection are associated with poorer survival outcomes in patients with resected colon cancer

por Muñoz-Montaño, Wendy R., López-Basave, Horacio N., Castillo-Morales, Alison, Castillo-Morales, Carolina, Sánchez-Trejo, Karen, Catalán, Rodrigo, Díaz-Romero, Consuelo, Lino-Silva, Leonardo S., Maliachi-Díaz, Andrea, Ruiz-García, Erika, Herrera-Martínez, Marytere, Calderillo-Ruíz, German
Publicado 2023

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

por Arrieta, Oscar, Muñoz-Montaño, Wendy, Muñiz-Hernández, Sae, Campos, Saul, Catalán, Rodrigo, Soto-Molina, Herman, Guzmán Vázquez, Silvia, Díaz-Álvarez, Osvaldo, Martínez-Pacheco, Victor, Turcott, Jenny G., Ramos-Ramírez, Maritza, Cabrera-Miranda, Luis, Barrón, Feliciano, Cardona, Andrés F.
Publicado 2021